SM04690
-
Biologics
Samumed Phase 2b Trial in Knee Osteoarthritis Meets Primary Endpoints
SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) — Samumed announced today top-line data from its phase 2b trial of SM04690…
Read More »
SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) — Samumed announced today top-line data from its phase 2b trial of SM04690…
Read More »